IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis.

J Pathol Clin Res · 2018 · PMC5783975 · PMID 29416877

Europe PMC DOI

hedged sentence

0.0040

closest p · 0.1× alpha

0.0040

boldest claim

The sentences

highly significantp < 0.004actually significant

This increase was highly significant when comparing the scoring results by the Wilcoxon rank sum test ( p < 0.004).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.